Deutsche Bank’s AstraZeneca AZN Stock Holding History

Deutsche Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-9,971	Closed	-$701K	–	5127
2014 Q4	$701K	Buy	9,971 +99	+1%	+$7.09K	﹤0.01%	3444
2014 Q3	$705K	Buy	9,872 +9,372	+1,874%	+$686K	﹤0.01%	3262
2014 Q2	$37K	Buy	500 +62	+14%	+$4.48K	﹤0.01%	5059
2014 Q1	$1K	Buy	+438	New	+$28.3K	﹤0.01%	5417

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Deutsche Bank's AZN Position: Q1 2026 in Review

Deutsche Bank increased its AstraZeneca (AZN) stake by 4,471% in Q1 2026, buying an estimated $2.29B and bringing the position to 12,129,724 shares worth $2.39B. The position accounts for 0.79% of the portfolio, ranked #15.

Deutsche Bank first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Deutsche Bank held 12,129,724 shares of AstraZeneca worth $2.39B as of Q1 2026.
Deutsche Bank bought 11,864,378 AstraZeneca shares in Q1 2026, an estimated $2.29B.
AstraZeneca made up 0.79% of Deutsche Bank's portfolio in Q1 2026, its #15 holding.
Deutsche Bank first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.